Global Hereditary Angioedema Therapeutic Market Research Report 2026(Status and Outlook)
Hereditary Angioedema Therapeutic is the treatment for Hereditary Angioedema. Growing cases of hereditary angioedema (HAE) globally is a key market driver.The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
The global Hereditary Angioedema Therapeutic market size was estimated at USD 2367.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 5.10% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Hereditary Angioedema Therapeutic market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Hereditary Angioedema Therapeutic market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Hereditary Angioedema Therapeutic market.
Global Hereditary Angioedema Therapeutic Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
BioCryst Pharma
Ionis Pharma
Pharming Group
CSL Limited
Shire
Attune Pharma
Adverum Biotechnologies
KalVista Pharma
Market Segmentation (by Type)
Intravenous
Subcutaneous
Oral
Market Segmentation (by Application)
Hospitals
Clinics
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Hereditary Angioedema Therapeutic Market
Overview of the regional outlook of the Hereditary Angioedema Therapeutic Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Hereditary Angioedema Therapeutic Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Hereditary Angioedema Therapeutic, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
The global Hereditary Angioedema Therapeutic market size was estimated at USD 2367.0 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 5.10% during the forecast period.
This report offers a comprehensive and in-depth analysis of the global Hereditary Angioedema Therapeutic market, covering all critical facets from a broad macroeconomic overview to detailed micro-level insights. It examines market size, competitive landscape, emerging development trends, niche segments, key drivers and challenges, as well as conducts SWOT and value chain analyses.
The insights provided enable readers to understand the competitive dynamics within the industry and formulate effective strategies to enhance profitability and market positioning. Additionally, the report presents a clear framework for evaluating the current status and future outlook of business organizations operating in this sector.
A significant focus of this report lies in the competitive landscape of the global Hereditary Angioedema Therapeutic market. It offers detailed profiles of major players, including their market shares, performance metrics, product portfolios, and operational status. This enables stakeholders to identify leading competitors and gain a nuanced understanding of market rivalry and structure.
In summary, this report serves as an essential resource for industry participants, investors, researchers, consultants, and business strategists, as well as anyone planning to enter or expand their presence in the Hereditary Angioedema Therapeutic market.
Global Hereditary Angioedema Therapeutic Market: Market Segmentation Analysis
This research report provides a detailed segmentation of the market by region (country), key manufacturers, product type, and application. Market segmentation divides the overall market into distinct subsets based on factors such as product categories, end-user industries, geographic locations, and other relevant criteria.
A clear understanding of these market segments enables decision-makers to tailor their product development, sales, and marketing strategies more effectively to meet the unique needs of each segment. Leveraging market segmentation insights can significantly enhance targeted approaches, optimize resource allocation, and accelerate product innovation cycles by aligning offerings with the specific demands of diverse customer groups.
Key Company
BioCryst Pharma
Ionis Pharma
Pharming Group
CSL Limited
Shire
Attune Pharma
Adverum Biotechnologies
KalVista Pharma
Market Segmentation (by Type)
Intravenous
Subcutaneous
Oral
Market Segmentation (by Application)
Hospitals
Clinics
Others
Geographic Segmentation
North America (USA, Canada, Mexico)
Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
South America (Brazil, Argentina, Columbia, Rest of South America)
The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
Industry drivers, restraints, and opportunities covered in the study
Neutral perspective on the market performance
Recent industry trends and developments
Competitive landscape & strategies of key players
Potential & niche segments and regions exhibiting promising growth covered
Historical, current, and projected market size, in terms of value
In-depth analysis of the Hereditary Angioedema Therapeutic Market
Overview of the regional outlook of the Hereditary Angioedema Therapeutic Market:
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
Chapter Outline
Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.
Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Hereditary Angioedema Therapeutic Market and its likely evolution in the short to mid-term, and long term.
Chapter 3 makes a detailed analysis of the market's competitive landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.
Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.
Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 9 shares the main producing countries of Hereditary Angioedema Therapeutic, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.
Chapter 11 provides a quantitative analysis of the market size and development potential of each region in the next five years.
Chapter 12 provides a quantitative analysis of the market size and development potential of each market segment in the next five years.
Chapter 13 is the main points and conclusions of the report.
Key Reasons to Buy this Report:
Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
This enables you to anticipate market changes to remain ahead of your competitors
You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
Provision of market value data for each segment and sub-segment
Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
Includes in-depth analysis of the market from various perspectives through Porter?s five forces analysis
Provides insight into the market through Value Chain
Market dynamics scenario, along with growth opportunities of the market in the years to come
6-month post-sales analyst support
Customization of the Report
In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.
1 RESEARCH METHODOLOGY AND STATISTICAL SCOPE
1.1 Market Definition and Statistical Scope of Hereditary Angioedema Therapeutic
1.2 Key Market Segments
1.2.1 Hereditary Angioedema Therapeutic Segment by Type
1.2.2 Hereditary Angioedema Therapeutic Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 HEREDITARY ANGIOEDEMA THERAPEUTIC MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Hereditary Angioedema Therapeutic Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Hereditary Angioedema Therapeutic Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 HEREDITARY ANGIOEDEMA THERAPEUTIC MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Hereditary Angioedema Therapeutic Product Life Cycle
3.3 Global Hereditary Angioedema Therapeutic Sales by Manufacturers (2020-2025)
3.4 Global Hereditary Angioedema Therapeutic Revenue Market Share by Manufacturers (2020-2025)
3.5 Hereditary Angioedema Therapeutic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Hereditary Angioedema Therapeutic Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Hereditary Angioedema Therapeutic Market Competitive Situation and Trends
3.8.1 Hereditary Angioedema Therapeutic Market Concentration Rate
3.8.2 Global 5 and 10 Largest Hereditary Angioedema Therapeutic Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 HEREDITARY ANGIOEDEMA THERAPEUTIC INDUSTRY CHAIN ANALYSIS
4.1 Hereditary Angioedema Therapeutic Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF HEREDITARY ANGIOEDEMA THERAPEUTIC MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Hereditary Angioedema Therapeutic Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Hereditary Angioedema Therapeutic Market
5.7 ESG Ratings of Leading Companies
6 HEREDITARY ANGIOEDEMA THERAPEUTIC MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Hereditary Angioedema Therapeutic Sales Market Share by Type (2020-2025)
6.3 Global Hereditary Angioedema Therapeutic Market Size by Type (2020-2025)
6.4 Global Hereditary Angioedema Therapeutic Price by Type (2020-2025)
7 HEREDITARY ANGIOEDEMA THERAPEUTIC MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Hereditary Angioedema Therapeutic Market Sales by Application (2020-2025)
7.3 Global Hereditary Angioedema Therapeutic Market Size (M USD) by Application (2020-2025)
7.4 Global Hereditary Angioedema Therapeutic Sales Growth Rate by Application (2020-2025)
8 HEREDITARY ANGIOEDEMA THERAPEUTIC MARKET SALES BY REGION
8.1 Global Hereditary Angioedema Therapeutic Sales by Region
8.1.1 Global Hereditary Angioedema Therapeutic Sales by Region
8.1.2 Global Hereditary Angioedema Therapeutic Sales Market Share by Region
8.2 Global Hereditary Angioedema Therapeutic Market Size by Region
8.2.1 Global Hereditary Angioedema Therapeutic Market Size by Region
8.2.2 Global Hereditary Angioedema Therapeutic Market Size by Region
8.3 North America
8.3.1 North America Hereditary Angioedema Therapeutic Sales by Country
8.3.2 North America Hereditary Angioedema Therapeutic Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Hereditary Angioedema Therapeutic Sales by Country
8.4.2 Europe Hereditary Angioedema Therapeutic Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Hereditary Angioedema Therapeutic Sales by Region
8.5.2 Asia Pacific Hereditary Angioedema Therapeutic Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Hereditary Angioedema Therapeutic Sales by Country
8.6.2 South America Hereditary Angioedema Therapeutic Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Hereditary Angioedema Therapeutic Sales by Region
8.7.2 Middle East and Africa Hereditary Angioedema Therapeutic Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 HEREDITARY ANGIOEDEMA THERAPEUTIC MARKET PRODUCTION BY REGION
9.1 Global Production of Hereditary Angioedema Therapeutic by Region(2020-2025)
9.2 Global Hereditary Angioedema Therapeutic Revenue Market Share by Region (2020-2025)
9.3 Global Hereditary Angioedema Therapeutic Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Hereditary Angioedema Therapeutic Production
9.4.1 North America Hereditary Angioedema Therapeutic Production Growth Rate (2020-2025)
9.4.2 North America Hereditary Angioedema Therapeutic Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Hereditary Angioedema Therapeutic Production
9.5.1 Europe Hereditary Angioedema Therapeutic Production Growth Rate (2020-2025)
9.5.2 Europe Hereditary Angioedema Therapeutic Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Hereditary Angioedema Therapeutic Production (2020-2025)
9.6.1 Japan Hereditary Angioedema Therapeutic Production Growth Rate (2020-2025)
9.6.2 Japan Hereditary Angioedema Therapeutic Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Hereditary Angioedema Therapeutic Production (2020-2025)
9.7.1 China Hereditary Angioedema Therapeutic Production Growth Rate (2020-2025)
9.7.2 China Hereditary Angioedema Therapeutic Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 BioCryst Pharma
10.1.1 BioCryst Pharma Basic Information
10.1.2 BioCryst Pharma Hereditary Angioedema Therapeutic Product Overview
10.1.3 BioCryst Pharma Hereditary Angioedema Therapeutic Product Market Performance
10.1.4 BioCryst Pharma Business Overview
10.1.5 BioCryst Pharma SWOT Analysis
10.1.6 BioCryst Pharma Recent Developments
10.2 Ionis Pharma
10.2.1 Ionis Pharma Basic Information
10.2.2 Ionis Pharma Hereditary Angioedema Therapeutic Product Overview
10.2.3 Ionis Pharma Hereditary Angioedema Therapeutic Product Market Performance
10.2.4 Ionis Pharma Business Overview
10.2.5 Ionis Pharma SWOT Analysis
10.2.6 Ionis Pharma Recent Developments
10.3 Pharming Group
10.3.1 Pharming Group Basic Information
10.3.2 Pharming Group Hereditary Angioedema Therapeutic Product Overview
10.3.3 Pharming Group Hereditary Angioedema Therapeutic Product Market Performance
10.3.4 Pharming Group Business Overview
10.3.5 Pharming Group SWOT Analysis
10.3.6 Pharming Group Recent Developments
10.4 CSL Limited
10.4.1 CSL Limited Basic Information
10.4.2 CSL Limited Hereditary Angioedema Therapeutic Product Overview
10.4.3 CSL Limited Hereditary Angioedema Therapeutic Product Market Performance
10.4.4 CSL Limited Business Overview
10.4.5 CSL Limited Recent Developments
10.5 Shire
10.5.1 Shire Basic Information
10.5.2 Shire Hereditary Angioedema Therapeutic Product Overview
10.5.3 Shire Hereditary Angioedema Therapeutic Product Market Performance
10.5.4 Shire Business Overview
10.5.5 Shire Recent Developments
10.6 Attune Pharma
10.6.1 Attune Pharma Basic Information
10.6.2 Attune Pharma Hereditary Angioedema Therapeutic Product Overview
10.6.3 Attune Pharma Hereditary Angioedema Therapeutic Product Market Performance
10.6.4 Attune Pharma Business Overview
10.6.5 Attune Pharma Recent Developments
10.7 Adverum Biotechnologies
10.7.1 Adverum Biotechnologies Basic Information
10.7.2 Adverum Biotechnologies Hereditary Angioedema Therapeutic Product Overview
10.7.3 Adverum Biotechnologies Hereditary Angioedema Therapeutic Product Market Performance
10.7.4 Adverum Biotechnologies Business Overview
10.7.5 Adverum Biotechnologies Recent Developments
10.8 KalVista Pharma
10.8.1 KalVista Pharma Basic Information
10.8.2 KalVista Pharma Hereditary Angioedema Therapeutic Product Overview
10.8.3 KalVista Pharma Hereditary Angioedema Therapeutic Product Market Performance
10.8.4 KalVista Pharma Business Overview
10.8.5 KalVista Pharma Recent Developments
11 HEREDITARY ANGIOEDEMA THERAPEUTIC MARKET FORECAST BY REGION
11.1 Global Hereditary Angioedema Therapeutic Market Size Forecast
11.2 Global Hereditary Angioedema Therapeutic Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Hereditary Angioedema Therapeutic Market Size Forecast by Country
11.2.3 Asia Pacific Hereditary Angioedema Therapeutic Market Size Forecast by Region
11.2.4 South America Hereditary Angioedema Therapeutic Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Hereditary Angioedema Therapeutic by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Hereditary Angioedema Therapeutic Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Hereditary Angioedema Therapeutic by Type (2026-2035)
12.1.2 Global Hereditary Angioedema Therapeutic Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Hereditary Angioedema Therapeutic by Type (2026-2035)
12.2 Global Hereditary Angioedema Therapeutic Market Forecast by Application (2026-2035)
12.2.1 Global Hereditary Angioedema Therapeutic Sales (K MT) Forecast by Application
12.2.2 Global Hereditary Angioedema Therapeutic Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
1.1 Market Definition and Statistical Scope of Hereditary Angioedema Therapeutic
1.2 Key Market Segments
1.2.1 Hereditary Angioedema Therapeutic Segment by Type
1.2.2 Hereditary Angioedema Therapeutic Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 HEREDITARY ANGIOEDEMA THERAPEUTIC MARKET OVERVIEW
2.1 Global Market Overview
2.1.1 Global Hereditary Angioedema Therapeutic Market Size (M USD) Estimates and Forecasts (2020-2035)
2.1.2 Global Hereditary Angioedema Therapeutic Sales Estimates and Forecasts (2020-2035)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 HEREDITARY ANGIOEDEMA THERAPEUTIC MARKET COMPETITIVE LANDSCAPE
3.1 Company Assessment Quadrant
3.2 Global Hereditary Angioedema Therapeutic Product Life Cycle
3.3 Global Hereditary Angioedema Therapeutic Sales by Manufacturers (2020-2025)
3.4 Global Hereditary Angioedema Therapeutic Revenue Market Share by Manufacturers (2020-2025)
3.5 Hereditary Angioedema Therapeutic Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.6 Global Hereditary Angioedema Therapeutic Average Price by Manufacturers (2020-2025)
3.7 Manufacturers? Manufacturing Sites, Areas Served, and Product Types
3.8 Hereditary Angioedema Therapeutic Market Competitive Situation and Trends
3.8.1 Hereditary Angioedema Therapeutic Market Concentration Rate
3.8.2 Global 5 and 10 Largest Hereditary Angioedema Therapeutic Players Market Share by Revenue
3.8.3 Mergers & Acquisitions, Expansion
4 HEREDITARY ANGIOEDEMA THERAPEUTIC INDUSTRY CHAIN ANALYSIS
4.1 Hereditary Angioedema Therapeutic Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 THE DEVELOPMENT AND DYNAMICS OF HEREDITARY ANGIOEDEMA THERAPEUTIC MARKET
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Industry News
5.4.1 New Product Developments
5.4.2 Mergers & Acquisitions
5.4.3 Expansions
5.4.4 Collaboration/Supply Contracts
5.5 PEST Analysis
5.5.1 Industry Policies Analysis
5.5.2 Economic Environment Analysis
5.5.3 Social Environment Analysis
5.5.4 Technological Environment Analysis
5.6 Global Hereditary Angioedema Therapeutic Market Porter's Five Forces Analysis
5.6.1 Global Trade Frictions
5.6.2 U.S. Tariff Policy ? April 2025
5.6.3 Global Trade Frictions and Their Impacts to Hereditary Angioedema Therapeutic Market
5.7 ESG Ratings of Leading Companies
6 HEREDITARY ANGIOEDEMA THERAPEUTIC MARKET SEGMENTATION BY TYPE
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Hereditary Angioedema Therapeutic Sales Market Share by Type (2020-2025)
6.3 Global Hereditary Angioedema Therapeutic Market Size by Type (2020-2025)
6.4 Global Hereditary Angioedema Therapeutic Price by Type (2020-2025)
7 HEREDITARY ANGIOEDEMA THERAPEUTIC MARKET SEGMENTATION BY APPLICATION
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Hereditary Angioedema Therapeutic Market Sales by Application (2020-2025)
7.3 Global Hereditary Angioedema Therapeutic Market Size (M USD) by Application (2020-2025)
7.4 Global Hereditary Angioedema Therapeutic Sales Growth Rate by Application (2020-2025)
8 HEREDITARY ANGIOEDEMA THERAPEUTIC MARKET SALES BY REGION
8.1 Global Hereditary Angioedema Therapeutic Sales by Region
8.1.1 Global Hereditary Angioedema Therapeutic Sales by Region
8.1.2 Global Hereditary Angioedema Therapeutic Sales Market Share by Region
8.2 Global Hereditary Angioedema Therapeutic Market Size by Region
8.2.1 Global Hereditary Angioedema Therapeutic Market Size by Region
8.2.2 Global Hereditary Angioedema Therapeutic Market Size by Region
8.3 North America
8.3.1 North America Hereditary Angioedema Therapeutic Sales by Country
8.3.2 North America Hereditary Angioedema Therapeutic Market Size by Country
8.3.3 U.S. Market Overview
8.3.4 Canada Market Overview
8.3.5 Mexico Market Overview
8.4 Europe
8.4.1 Europe Hereditary Angioedema Therapeutic Sales by Country
8.4.2 Europe Hereditary Angioedema Therapeutic Market Size by Country
8.4.3 Germany Market Overview
8.4.4 France Market Overview
8.4.5 U.K. Market Overview
8.4.6 Italy Market Overview
8.4.7 Spain Market Overview
8.5 Asia Pacific
8.5.1 Asia Pacific Hereditary Angioedema Therapeutic Sales by Region
8.5.2 Asia Pacific Hereditary Angioedema Therapeutic Market Size by Region
8.5.3 China Market Overview
8.5.4 Japan Market Overview
8.5.5 South Korea Market Overview
8.5.6 India Market Overview
8.5.7 Southeast Asia Market Overview
8.6 South America
8.6.1 South America Hereditary Angioedema Therapeutic Sales by Country
8.6.2 South America Hereditary Angioedema Therapeutic Market Size by Country
8.6.3 Brazil Market Overview
8.6.4 Argentina Market Overview
8.6.5 Columbia Market Overview
8.7 Middle East and Africa
8.7.1 Middle East and Africa Hereditary Angioedema Therapeutic Sales by Region
8.7.2 Middle East and Africa Hereditary Angioedema Therapeutic Market Size by Region
8.7.3 Saudi Arabia Market Overview
8.7.4 UAE Market Overview
8.7.5 Egypt Market Overview
8.7.6 Nigeria Market Overview
8.7.7 South Africa Market Overview
9 HEREDITARY ANGIOEDEMA THERAPEUTIC MARKET PRODUCTION BY REGION
9.1 Global Production of Hereditary Angioedema Therapeutic by Region(2020-2025)
9.2 Global Hereditary Angioedema Therapeutic Revenue Market Share by Region (2020-2025)
9.3 Global Hereditary Angioedema Therapeutic Production, Revenue, Price and Gross Margin (2020-2025)
9.4 North America Hereditary Angioedema Therapeutic Production
9.4.1 North America Hereditary Angioedema Therapeutic Production Growth Rate (2020-2025)
9.4.2 North America Hereditary Angioedema Therapeutic Production, Revenue, Price and Gross Margin (2020-2025)
9.5 Europe Hereditary Angioedema Therapeutic Production
9.5.1 Europe Hereditary Angioedema Therapeutic Production Growth Rate (2020-2025)
9.5.2 Europe Hereditary Angioedema Therapeutic Production, Revenue, Price and Gross Margin (2020-2025)
9.6 Japan Hereditary Angioedema Therapeutic Production (2020-2025)
9.6.1 Japan Hereditary Angioedema Therapeutic Production Growth Rate (2020-2025)
9.6.2 Japan Hereditary Angioedema Therapeutic Production, Revenue, Price and Gross Margin (2020-2025)
9.7 China Hereditary Angioedema Therapeutic Production (2020-2025)
9.7.1 China Hereditary Angioedema Therapeutic Production Growth Rate (2020-2025)
9.7.2 China Hereditary Angioedema Therapeutic Production, Revenue, Price and Gross Margin (2020-2025)
10 KEY COMPANIES PROFILE
10.1 BioCryst Pharma
10.1.1 BioCryst Pharma Basic Information
10.1.2 BioCryst Pharma Hereditary Angioedema Therapeutic Product Overview
10.1.3 BioCryst Pharma Hereditary Angioedema Therapeutic Product Market Performance
10.1.4 BioCryst Pharma Business Overview
10.1.5 BioCryst Pharma SWOT Analysis
10.1.6 BioCryst Pharma Recent Developments
10.2 Ionis Pharma
10.2.1 Ionis Pharma Basic Information
10.2.2 Ionis Pharma Hereditary Angioedema Therapeutic Product Overview
10.2.3 Ionis Pharma Hereditary Angioedema Therapeutic Product Market Performance
10.2.4 Ionis Pharma Business Overview
10.2.5 Ionis Pharma SWOT Analysis
10.2.6 Ionis Pharma Recent Developments
10.3 Pharming Group
10.3.1 Pharming Group Basic Information
10.3.2 Pharming Group Hereditary Angioedema Therapeutic Product Overview
10.3.3 Pharming Group Hereditary Angioedema Therapeutic Product Market Performance
10.3.4 Pharming Group Business Overview
10.3.5 Pharming Group SWOT Analysis
10.3.6 Pharming Group Recent Developments
10.4 CSL Limited
10.4.1 CSL Limited Basic Information
10.4.2 CSL Limited Hereditary Angioedema Therapeutic Product Overview
10.4.3 CSL Limited Hereditary Angioedema Therapeutic Product Market Performance
10.4.4 CSL Limited Business Overview
10.4.5 CSL Limited Recent Developments
10.5 Shire
10.5.1 Shire Basic Information
10.5.2 Shire Hereditary Angioedema Therapeutic Product Overview
10.5.3 Shire Hereditary Angioedema Therapeutic Product Market Performance
10.5.4 Shire Business Overview
10.5.5 Shire Recent Developments
10.6 Attune Pharma
10.6.1 Attune Pharma Basic Information
10.6.2 Attune Pharma Hereditary Angioedema Therapeutic Product Overview
10.6.3 Attune Pharma Hereditary Angioedema Therapeutic Product Market Performance
10.6.4 Attune Pharma Business Overview
10.6.5 Attune Pharma Recent Developments
10.7 Adverum Biotechnologies
10.7.1 Adverum Biotechnologies Basic Information
10.7.2 Adverum Biotechnologies Hereditary Angioedema Therapeutic Product Overview
10.7.3 Adverum Biotechnologies Hereditary Angioedema Therapeutic Product Market Performance
10.7.4 Adverum Biotechnologies Business Overview
10.7.5 Adverum Biotechnologies Recent Developments
10.8 KalVista Pharma
10.8.1 KalVista Pharma Basic Information
10.8.2 KalVista Pharma Hereditary Angioedema Therapeutic Product Overview
10.8.3 KalVista Pharma Hereditary Angioedema Therapeutic Product Market Performance
10.8.4 KalVista Pharma Business Overview
10.8.5 KalVista Pharma Recent Developments
11 HEREDITARY ANGIOEDEMA THERAPEUTIC MARKET FORECAST BY REGION
11.1 Global Hereditary Angioedema Therapeutic Market Size Forecast
11.2 Global Hereditary Angioedema Therapeutic Market Forecast by Region
11.2.1 North America Market Size Forecast by Country
11.2.2 Europe Hereditary Angioedema Therapeutic Market Size Forecast by Country
11.2.3 Asia Pacific Hereditary Angioedema Therapeutic Market Size Forecast by Region
11.2.4 South America Hereditary Angioedema Therapeutic Market Size Forecast by Country
11.2.5 Middle East and Africa Forecasted Sales of Hereditary Angioedema Therapeutic by Country
12 FORECAST MARKET BY TYPE AND BY APPLICATION (2026-2035)
12.1 Global Hereditary Angioedema Therapeutic Market Forecast by Type (2026-2035)
12.1.1 Global Forecasted Sales of Hereditary Angioedema Therapeutic by Type (2026-2035)
12.1.2 Global Hereditary Angioedema Therapeutic Market Size Forecast by Type (2026-2035)
12.1.3 Global Forecasted Price of Hereditary Angioedema Therapeutic by Type (2026-2035)
12.2 Global Hereditary Angioedema Therapeutic Market Forecast by Application (2026-2035)
12.2.1 Global Hereditary Angioedema Therapeutic Sales (K MT) Forecast by Application
12.2.2 Global Hereditary Angioedema Therapeutic Market Size (M USD) Forecast by Application (2026-2035)
13 CONCLUSION AND KEY FINDINGS
LIST OF TABLES
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Hereditary Angioedema Therapeutic Market Size by Type (M USD)
Table 4. Global Hereditary Angioedema Therapeutic Market Size by Application
Table 5. Hereditary Angioedema Therapeutic Market Size Comparison by Region (M USD)
Table 6. Global Hereditary Angioedema Therapeutic Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Hereditary Angioedema Therapeutic Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Hereditary Angioedema Therapeutic Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Hereditary Angioedema Therapeutic Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hereditary Angioedema Therapeutic as of 2025)
Table 11. Global Market Hereditary Angioedema Therapeutic Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Hereditary Angioedema Therapeutic Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Hereditary Angioedema Therapeutic Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Hereditary Angioedema Therapeutic Sales by Type (K MT)
Table 27. Global Hereditary Angioedema Therapeutic Market Size by Type (M USD)
Table 28. Global Hereditary Angioedema Therapeutic Sales (K MT) by Type (2020-2025)
Table 29. Global Hereditary Angioedema Therapeutic Sales Market Share by Type (2020-2025)
Table 30. Global Hereditary Angioedema Therapeutic Market Size (M USD) by Type (2020-2025)
Table 31. Global Hereditary Angioedema Therapeutic Market Share by Type (2020-2025)
Table 32. Global Hereditary Angioedema Therapeutic Price (USD/KG) by Type (2020-2025)
Table 33. Global Hereditary Angioedema Therapeutic Sales (K MT) by Application
Table 34. Global Hereditary Angioedema Therapeutic Market Size by Application
Table 35. Global Hereditary Angioedema Therapeutic Sales by Application (2020-2025) & (K MT)
Table 36. Global Hereditary Angioedema Therapeutic Sales Market Share by Application (2020-2025)
Table 37. Global Hereditary Angioedema Therapeutic Market Size by Application (2020-2025) & (M USD)
Table 38. Global Hereditary Angioedema Therapeutic Market Share by Application (2020-2025)
Table 39. Global Hereditary Angioedema Therapeutic Sales Growth Rate by Application (2020-2025)
Table 40. Global Hereditary Angioedema Therapeutic Sales by Region (2020-2025) & (K MT)
Table 41. Global Hereditary Angioedema Therapeutic Sales Market Share by Region (2020-2025)
Table 42. Global Hereditary Angioedema Therapeutic Market Size by Region (2020-2025) & (M USD)
Table 43. Global Hereditary Angioedema Therapeutic Market Size by Region (2020-2025)
Table 44. North America Hereditary Angioedema Therapeutic Sales by Country (2020-2025) & (K MT)
Table 45. North America Hereditary Angioedema Therapeutic Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Hereditary Angioedema Therapeutic Sales by Country (2020-2025) & (K MT)
Table 47. Europe Hereditary Angioedema Therapeutic Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Hereditary Angioedema Therapeutic Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Hereditary Angioedema Therapeutic Market Size by Region (2020-2025) & (M USD)
Table 50. South America Hereditary Angioedema Therapeutic Sales by Country (2020-2025) & (K MT)
Table 51. South America Hereditary Angioedema Therapeutic Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Hereditary Angioedema Therapeutic Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Hereditary Angioedema Therapeutic Market Size by Region (2020-2025) & (M USD)
Table 54. Global Hereditary Angioedema Therapeutic Production (K MT) by Region(2020-2025)
Table 55. Global Hereditary Angioedema Therapeutic Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Hereditary Angioedema Therapeutic Revenue Market Share by Region (2020-2025)
Table 57. Global Hereditary Angioedema Therapeutic Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Hereditary Angioedema Therapeutic Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Hereditary Angioedema Therapeutic Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Hereditary Angioedema Therapeutic Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Hereditary Angioedema Therapeutic Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. BioCryst Pharma Basic Information
Table 63. BioCryst Pharma Hereditary Angioedema Therapeutic Product Overview
Table 64. BioCryst Pharma Hereditary Angioedema Therapeutic Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. BioCryst Pharma Business Overview
Table 66. BioCryst Pharma SWOT Analysis
Table 67. BioCryst Pharma Recent Developments
Table 68. Ionis Pharma Basic Information
Table 69. Ionis Pharma Hereditary Angioedema Therapeutic Product Overview
Table 70. Ionis Pharma Hereditary Angioedema Therapeutic Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Ionis Pharma Business Overview
Table 72. Ionis Pharma SWOT Analysis
Table 73. Ionis Pharma Recent Developments
Table 74. Pharming Group Basic Information
Table 75. Pharming Group Hereditary Angioedema Therapeutic Product Overview
Table 76. Pharming Group Hereditary Angioedema Therapeutic Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Pharming Group Business Overview
Table 78. Pharming Group SWOT Analysis
Table 79. Pharming Group Recent Developments
Table 80. CSL Limited Basic Information
Table 81. CSL Limited Hereditary Angioedema Therapeutic Product Overview
Table 82. CSL Limited Hereditary Angioedema Therapeutic Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. CSL Limited Business Overview
Table 84. CSL Limited Recent Developments
Table 85. Shire Basic Information
Table 86. Shire Hereditary Angioedema Therapeutic Product Overview
Table 87. Shire Hereditary Angioedema Therapeutic Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Shire Business Overview
Table 89. Shire Recent Developments
Table 90. Attune Pharma Basic Information
Table 91. Attune Pharma Hereditary Angioedema Therapeutic Product Overview
Table 92. Attune Pharma Hereditary Angioedema Therapeutic Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Attune Pharma Business Overview
Table 94. Attune Pharma Recent Developments
Table 95. Adverum Biotechnologies Basic Information
Table 96. Adverum Biotechnologies Hereditary Angioedema Therapeutic Product Overview
Table 97. Adverum Biotechnologies Hereditary Angioedema Therapeutic Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Adverum Biotechnologies Business Overview
Table 99. Adverum Biotechnologies Recent Developments
Table 100. KalVista Pharma Basic Information
Table 101. KalVista Pharma Hereditary Angioedema Therapeutic Product Overview
Table 102. KalVista Pharma Hereditary Angioedema Therapeutic Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. KalVista Pharma Business Overview
Table 104. KalVista Pharma Recent Developments
Table 105. Global Hereditary Angioedema Therapeutic Sales Forecast by Region (2026-2035) & (K MT)
Table 106. Global Hereditary Angioedema Therapeutic Market Size Forecast by Region (2026-2035) & (M USD)
Table 107. North America Hereditary Angioedema Therapeutic Sales Forecast by Country (2026-2035) & (K MT)
Table 108. North America Hereditary Angioedema Therapeutic Market Size Forecast by Country (2026-2035) & (M USD)
Table 109. Europe Hereditary Angioedema Therapeutic Sales Forecast by Country (2026-2035) & (K MT)
Table 110. Europe Hereditary Angioedema Therapeutic Market Size Forecast by Country (2026-2035) & (M USD)
Table 111. Asia Pacific Hereditary Angioedema Therapeutic Sales Forecast by Region (2026-2035) & (K MT)
Table 112. Asia Pacific Hereditary Angioedema Therapeutic Market Size Forecast by Region (2026-2035) & (M USD)
Table 113. South America Hereditary Angioedema Therapeutic Sales Forecast by Country (2026-2035) & (K MT)
Table 114. South America Hereditary Angioedema Therapeutic Market Size Forecast by Country (2026-2035) & (M USD)
Table 115. Middle East and Africa Hereditary Angioedema Therapeutic Sales Forecast by Country (2026-2035) & (Units)
Table 116. Middle East and Africa Hereditary Angioedema Therapeutic Market Size Forecast by Country (2026-2035) & (M USD)
Table 117. Global Hereditary Angioedema Therapeutic Sales Forecast by Type (2026-2035) & (K MT)
Table 118. Global Hereditary Angioedema Therapeutic Market Size Forecast by Type (2026-2035) & (M USD)
Table 119. Global Hereditary Angioedema Therapeutic Price Forecast by Type (2026-2035) & (USD/KG)
Table 120. Global Hereditary Angioedema Therapeutic Sales (K MT) Forecast by Application (2026-2035)
Table 121. Global Hereditary Angioedema Therapeutic Market Size Forecast by Application (2026-2035) & (M USD)
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Hereditary Angioedema Therapeutic Market Size by Type (M USD)
Table 4. Global Hereditary Angioedema Therapeutic Market Size by Application
Table 5. Hereditary Angioedema Therapeutic Market Size Comparison by Region (M USD)
Table 6. Global Hereditary Angioedema Therapeutic Sales (K MT) by Manufacturers (2020-2025)
Table 7. Global Hereditary Angioedema Therapeutic Sales Market Share by Manufacturers (2020-2025)
Table 8. Global Hereditary Angioedema Therapeutic Revenue (M USD) by Manufacturers (2020-2025)
Table 9. Global Hereditary Angioedema Therapeutic Revenue Share by Manufacturers (2020-2025)
Table 10. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hereditary Angioedema Therapeutic as of 2025)
Table 11. Global Market Hereditary Angioedema Therapeutic Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 12. Manufacturers? Manufacturing Sites, Areas Served
Table 13. Manufacturers? Product Type
Table 14. Global Hereditary Angioedema Therapeutic Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 15. Mergers & Acquisitions, Expansion Plans
Table 16. Market Overview of Key Raw Materials
Table 17. Midstream Market Analysis
Table 18. Downstream Customer Analysis
Table 19. Key Development Trends
Table 20. Driving Factors
Table 21. Hereditary Angioedema Therapeutic Market Challenges
Table 22. Goldman Sachs' forecast real GDP growth rate for 2025-2026
Table 23. S&P Global ' Forecast Real GDP Growth Rate For 2025-2027
Table 24. World Bank ' Forecast Real GDP Growth Rate For 2025-2026
Table 25. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 26. Global Hereditary Angioedema Therapeutic Sales by Type (K MT)
Table 27. Global Hereditary Angioedema Therapeutic Market Size by Type (M USD)
Table 28. Global Hereditary Angioedema Therapeutic Sales (K MT) by Type (2020-2025)
Table 29. Global Hereditary Angioedema Therapeutic Sales Market Share by Type (2020-2025)
Table 30. Global Hereditary Angioedema Therapeutic Market Size (M USD) by Type (2020-2025)
Table 31. Global Hereditary Angioedema Therapeutic Market Share by Type (2020-2025)
Table 32. Global Hereditary Angioedema Therapeutic Price (USD/KG) by Type (2020-2025)
Table 33. Global Hereditary Angioedema Therapeutic Sales (K MT) by Application
Table 34. Global Hereditary Angioedema Therapeutic Market Size by Application
Table 35. Global Hereditary Angioedema Therapeutic Sales by Application (2020-2025) & (K MT)
Table 36. Global Hereditary Angioedema Therapeutic Sales Market Share by Application (2020-2025)
Table 37. Global Hereditary Angioedema Therapeutic Market Size by Application (2020-2025) & (M USD)
Table 38. Global Hereditary Angioedema Therapeutic Market Share by Application (2020-2025)
Table 39. Global Hereditary Angioedema Therapeutic Sales Growth Rate by Application (2020-2025)
Table 40. Global Hereditary Angioedema Therapeutic Sales by Region (2020-2025) & (K MT)
Table 41. Global Hereditary Angioedema Therapeutic Sales Market Share by Region (2020-2025)
Table 42. Global Hereditary Angioedema Therapeutic Market Size by Region (2020-2025) & (M USD)
Table 43. Global Hereditary Angioedema Therapeutic Market Size by Region (2020-2025)
Table 44. North America Hereditary Angioedema Therapeutic Sales by Country (2020-2025) & (K MT)
Table 45. North America Hereditary Angioedema Therapeutic Market Size by Country (2020-2025) & (M USD)
Table 46. Europe Hereditary Angioedema Therapeutic Sales by Country (2020-2025) & (K MT)
Table 47. Europe Hereditary Angioedema Therapeutic Market Size by Country (2020-2025) & (M USD)
Table 48. Asia Pacific Hereditary Angioedema Therapeutic Sales by Region (2020-2025) & (K MT)
Table 49. Asia Pacific Hereditary Angioedema Therapeutic Market Size by Region (2020-2025) & (M USD)
Table 50. South America Hereditary Angioedema Therapeutic Sales by Country (2020-2025) & (K MT)
Table 51. South America Hereditary Angioedema Therapeutic Market Size by Country (2020-2025) & (M USD)
Table 52. Middle East and Africa Hereditary Angioedema Therapeutic Sales by Region (2020-2025) & (K MT)
Table 53. Middle East and Africa Hereditary Angioedema Therapeutic Market Size by Region (2020-2025) & (M USD)
Table 54. Global Hereditary Angioedema Therapeutic Production (K MT) by Region(2020-2025)
Table 55. Global Hereditary Angioedema Therapeutic Revenue (US$ Million) by Region (2020-2025)
Table 56. Global Hereditary Angioedema Therapeutic Revenue Market Share by Region (2020-2025)
Table 57. Global Hereditary Angioedema Therapeutic Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 58. North America Hereditary Angioedema Therapeutic Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 59. Europe Hereditary Angioedema Therapeutic Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. Japan Hereditary Angioedema Therapeutic Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. China Hereditary Angioedema Therapeutic Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. BioCryst Pharma Basic Information
Table 63. BioCryst Pharma Hereditary Angioedema Therapeutic Product Overview
Table 64. BioCryst Pharma Hereditary Angioedema Therapeutic Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 65. BioCryst Pharma Business Overview
Table 66. BioCryst Pharma SWOT Analysis
Table 67. BioCryst Pharma Recent Developments
Table 68. Ionis Pharma Basic Information
Table 69. Ionis Pharma Hereditary Angioedema Therapeutic Product Overview
Table 70. Ionis Pharma Hereditary Angioedema Therapeutic Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 71. Ionis Pharma Business Overview
Table 72. Ionis Pharma SWOT Analysis
Table 73. Ionis Pharma Recent Developments
Table 74. Pharming Group Basic Information
Table 75. Pharming Group Hereditary Angioedema Therapeutic Product Overview
Table 76. Pharming Group Hereditary Angioedema Therapeutic Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 77. Pharming Group Business Overview
Table 78. Pharming Group SWOT Analysis
Table 79. Pharming Group Recent Developments
Table 80. CSL Limited Basic Information
Table 81. CSL Limited Hereditary Angioedema Therapeutic Product Overview
Table 82. CSL Limited Hereditary Angioedema Therapeutic Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 83. CSL Limited Business Overview
Table 84. CSL Limited Recent Developments
Table 85. Shire Basic Information
Table 86. Shire Hereditary Angioedema Therapeutic Product Overview
Table 87. Shire Hereditary Angioedema Therapeutic Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 88. Shire Business Overview
Table 89. Shire Recent Developments
Table 90. Attune Pharma Basic Information
Table 91. Attune Pharma Hereditary Angioedema Therapeutic Product Overview
Table 92. Attune Pharma Hereditary Angioedema Therapeutic Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 93. Attune Pharma Business Overview
Table 94. Attune Pharma Recent Developments
Table 95. Adverum Biotechnologies Basic Information
Table 96. Adverum Biotechnologies Hereditary Angioedema Therapeutic Product Overview
Table 97. Adverum Biotechnologies Hereditary Angioedema Therapeutic Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 98. Adverum Biotechnologies Business Overview
Table 99. Adverum Biotechnologies Recent Developments
Table 100. KalVista Pharma Basic Information
Table 101. KalVista Pharma Hereditary Angioedema Therapeutic Product Overview
Table 102. KalVista Pharma Hereditary Angioedema Therapeutic Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 103. KalVista Pharma Business Overview
Table 104. KalVista Pharma Recent Developments
Table 105. Global Hereditary Angioedema Therapeutic Sales Forecast by Region (2026-2035) & (K MT)
Table 106. Global Hereditary Angioedema Therapeutic Market Size Forecast by Region (2026-2035) & (M USD)
Table 107. North America Hereditary Angioedema Therapeutic Sales Forecast by Country (2026-2035) & (K MT)
Table 108. North America Hereditary Angioedema Therapeutic Market Size Forecast by Country (2026-2035) & (M USD)
Table 109. Europe Hereditary Angioedema Therapeutic Sales Forecast by Country (2026-2035) & (K MT)
Table 110. Europe Hereditary Angioedema Therapeutic Market Size Forecast by Country (2026-2035) & (M USD)
Table 111. Asia Pacific Hereditary Angioedema Therapeutic Sales Forecast by Region (2026-2035) & (K MT)
Table 112. Asia Pacific Hereditary Angioedema Therapeutic Market Size Forecast by Region (2026-2035) & (M USD)
Table 113. South America Hereditary Angioedema Therapeutic Sales Forecast by Country (2026-2035) & (K MT)
Table 114. South America Hereditary Angioedema Therapeutic Market Size Forecast by Country (2026-2035) & (M USD)
Table 115. Middle East and Africa Hereditary Angioedema Therapeutic Sales Forecast by Country (2026-2035) & (Units)
Table 116. Middle East and Africa Hereditary Angioedema Therapeutic Market Size Forecast by Country (2026-2035) & (M USD)
Table 117. Global Hereditary Angioedema Therapeutic Sales Forecast by Type (2026-2035) & (K MT)
Table 118. Global Hereditary Angioedema Therapeutic Market Size Forecast by Type (2026-2035) & (M USD)
Table 119. Global Hereditary Angioedema Therapeutic Price Forecast by Type (2026-2035) & (USD/KG)
Table 120. Global Hereditary Angioedema Therapeutic Sales (K MT) Forecast by Application (2026-2035)
Table 121. Global Hereditary Angioedema Therapeutic Market Size Forecast by Application (2026-2035) & (M USD)
LIST OF FIGURES
Figure 1. Product Picture of Hereditary Angioedema Therapeutic
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Hereditary Angioedema Therapeutic Market Size (M USD), 2025-2035
Figure 5. Global Hereditary Angioedema Therapeutic Market Size (M USD) (2020-2035)
Figure 6. Global Hereditary Angioedema Therapeutic Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Hereditary Angioedema Therapeutic Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Hereditary Angioedema Therapeutic Product Life Cycle
Figure 13. Hereditary Angioedema Therapeutic Sales Share by Manufacturers in 2025
Figure 14. Global Hereditary Angioedema Therapeutic Revenue Share by Manufacturers in 2025
Figure 15. Hereditary Angioedema Therapeutic Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Hereditary Angioedema Therapeutic Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Hereditary Angioedema Therapeutic Revenue in 2025
Figure 18. Industry Chain Map of Hereditary Angioedema Therapeutic
Figure 19. Global Hereditary Angioedema Therapeutic Market PEST Analysis
Figure 20. Global Hereditary Angioedema Therapeutic Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Hereditary Angioedema Therapeutic Market Share by Type
Figure 27. Sales Market Share of Hereditary Angioedema Therapeutic by Type (2020-2025)
Figure 28. Sales Market Share of Hereditary Angioedema Therapeutic by Type in 2025
Figure 29. Market Share of Hereditary Angioedema Therapeutic by Type (2020-2025)
Figure 30. Market Share of Hereditary Angioedema Therapeutic by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Hereditary Angioedema Therapeutic Market Share by Application
Figure 33. Global Hereditary Angioedema Therapeutic Sales Market Share by Application (2020-2025)
Figure 34. Global Hereditary Angioedema Therapeutic Sales Market Share by Application in 2025
Figure 35. Global Hereditary Angioedema Therapeutic Market Share by Application (2020-2025)
Figure 36. Global Hereditary Angioedema Therapeutic Market Share by Application in 2025
Figure 37. Global Hereditary Angioedema Therapeutic Sales Growth Rate by Application (2020-2025)
Figure 38. Global Hereditary Angioedema Therapeutic Sales Market Share by Region (2020-2025)
Figure 39. Global Hereditary Angioedema Therapeutic Market Size by Region (2020-2025)
Figure 40. North America Hereditary Angioedema Therapeutic Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Hereditary Angioedema Therapeutic Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Hereditary Angioedema Therapeutic Sales Market Share by Country in 2024
Figure 43. North America Hereditary Angioedema Therapeutic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Hereditary Angioedema Therapeutic Market Size by Country in 2024
Figure 45. U.S. Hereditary Angioedema Therapeutic Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Hereditary Angioedema Therapeutic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Hereditary Angioedema Therapeutic Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Hereditary Angioedema Therapeutic Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Hereditary Angioedema Therapeutic Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Hereditary Angioedema Therapeutic Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Hereditary Angioedema Therapeutic Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Hereditary Angioedema Therapeutic Sales Market Share by Country in 2024
Figure 53. Europe Hereditary Angioedema Therapeutic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Hereditary Angioedema Therapeutic Market Size by Country in 2024
Figure 55. Germany Hereditary Angioedema Therapeutic Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Hereditary Angioedema Therapeutic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Hereditary Angioedema Therapeutic Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Hereditary Angioedema Therapeutic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Hereditary Angioedema Therapeutic Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Hereditary Angioedema Therapeutic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Hereditary Angioedema Therapeutic Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Hereditary Angioedema Therapeutic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Hereditary Angioedema Therapeutic Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Hereditary Angioedema Therapeutic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Hereditary Angioedema Therapeutic Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Hereditary Angioedema Therapeutic Sales Market Share by Region in 2024
Figure 67. Asia Pacific Hereditary Angioedema Therapeutic Market Size by Region in 2024
Figure 68. China Hereditary Angioedema Therapeutic Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Hereditary Angioedema Therapeutic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Hereditary Angioedema Therapeutic Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Hereditary Angioedema Therapeutic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Hereditary Angioedema Therapeutic Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Hereditary Angioedema Therapeutic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Hereditary Angioedema Therapeutic Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Hereditary Angioedema Therapeutic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Hereditary Angioedema Therapeutic Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Hereditary Angioedema Therapeutic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Hereditary Angioedema Therapeutic Sales and Growth Rate (K MT)
Figure 79. South America Hereditary Angioedema Therapeutic Sales Market Share by Country in 2024
Figure 80. South America Hereditary Angioedema Therapeutic Market Size and Growth Rate (M USD)
Figure 81. South America Hereditary Angioedema Therapeutic Market Size by Country in 2024
Figure 82. Brazil Hereditary Angioedema Therapeutic Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Hereditary Angioedema Therapeutic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Hereditary Angioedema Therapeutic Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Hereditary Angioedema Therapeutic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Hereditary Angioedema Therapeutic Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Hereditary Angioedema Therapeutic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Hereditary Angioedema Therapeutic Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Hereditary Angioedema Therapeutic Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Hereditary Angioedema Therapeutic Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Hereditary Angioedema Therapeutic Market Size by Region in 2024
Figure 92. Saudi Arabia Hereditary Angioedema Therapeutic Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Hereditary Angioedema Therapeutic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Hereditary Angioedema Therapeutic Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Hereditary Angioedema Therapeutic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Hereditary Angioedema Therapeutic Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Hereditary Angioedema Therapeutic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Hereditary Angioedema Therapeutic Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Hereditary Angioedema Therapeutic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Hereditary Angioedema Therapeutic Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Hereditary Angioedema Therapeutic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Hereditary Angioedema Therapeutic Production Market Share by Region (2020-2025)
Figure 103. North America Hereditary Angioedema Therapeutic Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Hereditary Angioedema Therapeutic Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Hereditary Angioedema Therapeutic Production (K MT) Growth Rate (2020-2025)
Figure 106. China Hereditary Angioedema Therapeutic Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Hereditary Angioedema Therapeutic Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Hereditary Angioedema Therapeutic Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Hereditary Angioedema Therapeutic Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Hereditary Angioedema Therapeutic Market Share Forecast by Type (2026-2035)
Figure 111. Global Hereditary Angioedema Therapeutic Sales Forecast by Application (2026-2035)
Figure 112. Global Hereditary Angioedema Therapeutic Market Share Forecast by Application (2026-2035)
Figure 1. Product Picture of Hereditary Angioedema Therapeutic
Figure 2. Data Triangulation
Figure 3. Key Caveats
Figure 4. Global Hereditary Angioedema Therapeutic Market Size (M USD), 2025-2035
Figure 5. Global Hereditary Angioedema Therapeutic Market Size (M USD) (2020-2035)
Figure 6. Global Hereditary Angioedema Therapeutic Sales (K MT) & (2020-2035)
Figure 7. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 8. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 9. Evaluation Matrix of Regional Market Development Potential
Figure 10. Hereditary Angioedema Therapeutic Market Size by Country (M USD)
Figure 11. Company Assessment Quadrant
Figure 12. Global Hereditary Angioedema Therapeutic Product Life Cycle
Figure 13. Hereditary Angioedema Therapeutic Sales Share by Manufacturers in 2025
Figure 14. Global Hereditary Angioedema Therapeutic Revenue Share by Manufacturers in 2025
Figure 15. Hereditary Angioedema Therapeutic Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 16. Global Market Hereditary Angioedema Therapeutic Average Price (USD/KG) of Key Manufacturers in 2025
Figure 17. The Global 5 and 10 Largest Players: Market Share by Hereditary Angioedema Therapeutic Revenue in 2025
Figure 18. Industry Chain Map of Hereditary Angioedema Therapeutic
Figure 19. Global Hereditary Angioedema Therapeutic Market PEST Analysis
Figure 20. Global Hereditary Angioedema Therapeutic Market Porter's Five Forces Analysis
Figure 21. Global Merchandise Trade as a Percentage Of GDP
Figure 22. US - lmports of Goods by Country
Figure 23. China Exports by Country
Figure 24. ESG Rating Distribution of The Leading Company Compared With Its Peers
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Hereditary Angioedema Therapeutic Market Share by Type
Figure 27. Sales Market Share of Hereditary Angioedema Therapeutic by Type (2020-2025)
Figure 28. Sales Market Share of Hereditary Angioedema Therapeutic by Type in 2025
Figure 29. Market Share of Hereditary Angioedema Therapeutic by Type (2020-2025)
Figure 30. Market Share of Hereditary Angioedema Therapeutic by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Hereditary Angioedema Therapeutic Market Share by Application
Figure 33. Global Hereditary Angioedema Therapeutic Sales Market Share by Application (2020-2025)
Figure 34. Global Hereditary Angioedema Therapeutic Sales Market Share by Application in 2025
Figure 35. Global Hereditary Angioedema Therapeutic Market Share by Application (2020-2025)
Figure 36. Global Hereditary Angioedema Therapeutic Market Share by Application in 2025
Figure 37. Global Hereditary Angioedema Therapeutic Sales Growth Rate by Application (2020-2025)
Figure 38. Global Hereditary Angioedema Therapeutic Sales Market Share by Region (2020-2025)
Figure 39. Global Hereditary Angioedema Therapeutic Market Size by Region (2020-2025)
Figure 40. North America Hereditary Angioedema Therapeutic Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Hereditary Angioedema Therapeutic Sales and Growth Rate (2020-2025) & (K MT)
Figure 42. North America Hereditary Angioedema Therapeutic Sales Market Share by Country in 2024
Figure 43. North America Hereditary Angioedema Therapeutic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 44. North America Hereditary Angioedema Therapeutic Market Size by Country in 2024
Figure 45. U.S. Hereditary Angioedema Therapeutic Sales and Growth Rate (2020-2025) & (K MT)
Figure 46. U.S. Hereditary Angioedema Therapeutic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 47. Canada Hereditary Angioedema Therapeutic Sales (K MT) and Growth Rate (2020-2025)
Figure 48. Canada Hereditary Angioedema Therapeutic Market Size (M USD) and Growth Rate (2020-2025)
Figure 49. Mexico Hereditary Angioedema Therapeutic Sales (Units) and Growth Rate (2020-2025)
Figure 50. Mexico Hereditary Angioedema Therapeutic Market Size (Units) and Growth Rate (2020-2025)
Figure 51. Europe Hereditary Angioedema Therapeutic Sales and Growth Rate (2020-2025) & (K MT)
Figure 52. Europe Hereditary Angioedema Therapeutic Sales Market Share by Country in 2024
Figure 53. Europe Hereditary Angioedema Therapeutic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 54. Europe Hereditary Angioedema Therapeutic Market Size by Country in 2024
Figure 55. Germany Hereditary Angioedema Therapeutic Sales and Growth Rate (2020-2025) & (K MT)
Figure 56. Germany Hereditary Angioedema Therapeutic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 57. France Hereditary Angioedema Therapeutic Sales and Growth Rate (2020-2025) & (K MT)
Figure 58. France Hereditary Angioedema Therapeutic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 59. U.K. Hereditary Angioedema Therapeutic Sales and Growth Rate (2020-2025) & (K MT)
Figure 60. U.K. Hereditary Angioedema Therapeutic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 61. Italy Hereditary Angioedema Therapeutic Sales and Growth Rate (2020-2025) & (K MT)
Figure 62. Italy Hereditary Angioedema Therapeutic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 63. Spain Hereditary Angioedema Therapeutic Sales and Growth Rate (2020-2025) & (K MT)
Figure 64. Spain Hereditary Angioedema Therapeutic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 65. Asia Pacific Hereditary Angioedema Therapeutic Sales and Growth Rate (K MT)
Figure 66. Asia Pacific Hereditary Angioedema Therapeutic Sales Market Share by Region in 2024
Figure 67. Asia Pacific Hereditary Angioedema Therapeutic Market Size by Region in 2024
Figure 68. China Hereditary Angioedema Therapeutic Sales and Growth Rate (2020-2025) & (K MT)
Figure 69. China Hereditary Angioedema Therapeutic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 70. Japan Hereditary Angioedema Therapeutic Sales and Growth Rate (2020-2025) & (K MT)
Figure 71. Japan Hereditary Angioedema Therapeutic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 72. South Korea Hereditary Angioedema Therapeutic Sales and Growth Rate (2020-2025) & (K MT)
Figure 73. South Korea Hereditary Angioedema Therapeutic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 74. India Hereditary Angioedema Therapeutic Sales and Growth Rate (2020-2025) & (K MT)
Figure 75. India Hereditary Angioedema Therapeutic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 76. Southeast Asia Hereditary Angioedema Therapeutic Sales and Growth Rate (2020-2025) & (K MT)
Figure 77. Southeast Asia Hereditary Angioedema Therapeutic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 78. South America Hereditary Angioedema Therapeutic Sales and Growth Rate (K MT)
Figure 79. South America Hereditary Angioedema Therapeutic Sales Market Share by Country in 2024
Figure 80. South America Hereditary Angioedema Therapeutic Market Size and Growth Rate (M USD)
Figure 81. South America Hereditary Angioedema Therapeutic Market Size by Country in 2024
Figure 82. Brazil Hereditary Angioedema Therapeutic Sales and Growth Rate (2020-2025) & (K MT)
Figure 83. Brazil Hereditary Angioedema Therapeutic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 84. Argentina Hereditary Angioedema Therapeutic Sales and Growth Rate (2020-2025) & (K MT)
Figure 85. Argentina Hereditary Angioedema Therapeutic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 86. Columbia Hereditary Angioedema Therapeutic Sales and Growth Rate (2020-2025) & (K MT)
Figure 87. Columbia Hereditary Angioedema Therapeutic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 88. Middle East and Africa Hereditary Angioedema Therapeutic Sales and Growth Rate (K MT)
Figure 89. Middle East and Africa Hereditary Angioedema Therapeutic Sales Market Share by Region in 2024
Figure 90. Middle East and Africa Hereditary Angioedema Therapeutic Market Size and Growth Rate (M USD)
Figure 91. Middle East and Africa Hereditary Angioedema Therapeutic Market Size by Region in 2024
Figure 92. Saudi Arabia Hereditary Angioedema Therapeutic Sales and Growth Rate (2020-2025) & (K MT)
Figure 93. Saudi Arabia Hereditary Angioedema Therapeutic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 94. UAE Hereditary Angioedema Therapeutic Sales and Growth Rate (2020-2025) & (K MT)
Figure 95. UAE Hereditary Angioedema Therapeutic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 96. Egypt Hereditary Angioedema Therapeutic Sales and Growth Rate (2020-2025) & (K MT)
Figure 97. Egypt Hereditary Angioedema Therapeutic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 98. Nigeria Hereditary Angioedema Therapeutic Sales and Growth Rate (2020-2025) & (K MT)
Figure 99. Nigeria Hereditary Angioedema Therapeutic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 100. South Africa Hereditary Angioedema Therapeutic Sales and Growth Rate (2020-2025) & (K MT)
Figure 101. South Africa Hereditary Angioedema Therapeutic Market Size and Growth Rate (2020-2025) & (M USD)
Figure 102. Global Hereditary Angioedema Therapeutic Production Market Share by Region (2020-2025)
Figure 103. North America Hereditary Angioedema Therapeutic Production (K MT) Growth Rate (2020-2025)
Figure 104. Europe Hereditary Angioedema Therapeutic Production (K MT) Growth Rate (2020-2025)
Figure 105. Japan Hereditary Angioedema Therapeutic Production (K MT) Growth Rate (2020-2025)
Figure 106. China Hereditary Angioedema Therapeutic Production (K MT) Growth Rate (2020-2025)
Figure 107. Global Hereditary Angioedema Therapeutic Sales Forecast by Volume (2020-2035) & (K MT)
Figure 108. Global Hereditary Angioedema Therapeutic Market Size Forecast by Value (2020-2035) & (M USD)
Figure 109. Global Hereditary Angioedema Therapeutic Sales Market Share Forecast by Type (2026-2035)
Figure 110. Global Hereditary Angioedema Therapeutic Market Share Forecast by Type (2026-2035)
Figure 111. Global Hereditary Angioedema Therapeutic Sales Forecast by Application (2026-2035)
Figure 112. Global Hereditary Angioedema Therapeutic Market Share Forecast by Application (2026-2035)
